Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREPPE: Iatrogenic Chronotropic Incompetence in Heart Failure
NCT02247245Completed
- Sponsor
- University of Leeds
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ivabradine in chronic heart failure (CHF) (3 arms), sponsored by University of Leeds. Primary endpoint: Maximal Oxygen Consumption up to 20 minutes. Started Sep 2014; status: completed.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT02247245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247245.